ndd Medical Technologies And COPD Foundation Help Fight COPD In Chicago

Free Mobile Respiratory Screening Taking Place during COPD9USA on June 5

ANDOVER, Mass.--(BUSINESS WIRE)--ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT), announced that it is partnering with the COPD Foundation during its COPD9USA Conference to offer DLCO testing (diffusing capacity of the lungs for carbon monoxide), which provides an objective measure of lung function when screening for chronic obstructive pulmonary disease (COPD). ndd’s EasyOne Pro^® line of mobile ultrasound spirometry and pulmonary function testing equipment will be used during free lung health screenings from 9:00 am to 4:00 pm on June 5 at the Hyatt Regency O’Hare in Chicago, Illinois.

“We are pleased to be a part of this COPD Foundation screening event”

COPD is an umbrella term for progressive lung diseases that make breathing difficult, including emphysema, chronic bronchitis, non-reversible asthma, and some forms of bronchiectasis (a widening of the bronchial tubes in the lungs along with infection). In Illinois, nearly 6 percent of the population is affected by COPD. The COPD Foundation’s mission is to prevent and cure COPD and improve the lives of all people affected.

“COPD affects over 24 million Americans across all 50 states, of which only 12 million have been diagnosed,” said John W. Walsh, Co-founder and President of the COPD Foundation. “Since early screening can identify COPD before major loss of lung function occurs, it is vital to promote ongoing access to screening. A person may have COPD but not notice symptoms until it is in the moderate stage, so screening is an important tool to educate and help patients get tested and treated. We are grateful for partners like ndd Medical who make testing easy and accessible to those at risk. We must continue to offer such services and raise awareness about these invisible diseases.”

With a footprint of 12-square-inches, the EasyOne Pro can perform breathing tests in clinics, doctors’ offices and at the patient bedside. Its portability and accuracy allow for mobile PFTs in under 30 minutes so that patients’ time is used more efficiently when they receive an assessment of their condition.

Symptoms of COPD can include increased breathlessness, frequent coughing (with and without sputum), wheezing and tightness in the chest.

“We are pleased to be a part of this COPD Foundation screening event,” said Joy Tobin, Director of Marketing for ndd Medical Technologies. “We make time for such events to help educate and raise awareness of the prevalence of COPD, a disease that kills more women each year than breast cancer and diabetes combined. Many people remain undiagnosed, and a simple breathing test is one of the most effective ways to diagnose this deadly but treatable disease.”

About ndd Medical Technologies, Inc.

With over 40 percent of the U.S. spirometry market share, ndd Medical Technologies offers innovative, easy-to-use pulmonary function testing instruments that help clinicians diagnose lung disease with greater precision for optimal treatment. Its EasyOne^® and EasyOne Pro^® portable instruments take up just 12 square-inches of space and take lung function testing wherever it is needed, measuring DLCO, FRC, LCI and FVC. ndd’s patented Ultrasonic TrueFlow™ technology requires no calibration and eliminates problems associated with traditional methods of flow measurement, making testing fast, reliable and error-free. To learn more, visit www.nddmed.com.